Newbridge Financial Services Group, Inc. Humacyte, Inc. Transaction History
Newbridge Financial Services Group, Inc.
- $372 Million
- Q4 2024
A detailed history of Newbridge Financial Services Group, Inc. transactions in Humacyte, Inc. stock. As of the latest transaction made, Newbridge Financial Services Group, Inc. holds 60 shares of HUMA stock, worth $247. This represents 0.0% of its overall portfolio holdings.
Number of Shares
60Holding current value
$247% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HUMA
# of Institutions
160Shares Held
36.2MCall Options Held
284KPut Options Held
607K-
Black Rock Inc. New York, NY7.14MShares$29.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.06MShares$20.9 Million0.0% of portfolio
-
State Street Corp Boston, MA4.76MShares$19.7 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.04MShares$8.43 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.27MShares$5.23 Million0.0% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $425M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...